Patent ID: 11969470
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. A method of treating a subject having a condition selected from the group consisting of ischemic stroke, neonatal anoxia, conditions caused by exposure to sarin, neonatal seizures, simple partial seizures, complex partial seizures, secondarily generalized seizures, generalized seizures, typical absence seizures, atypical absence seizures, myoclonic seizures, tonic seizures, clonic seizures, generalized tonic-clonic seizures, atonic seizures, and seizures associated with juvenile myoclonic epilepsy, the method consisting of administering to the subject an effective amount of a composition consisting of topiramate or a salt thereof, one or more pharmaceutically acceptable carriers, and an additional compound of Formula (III):, wherein each R is independently selected from H or —(CH2)4—SO3Na, wherein the composition has a plurality of different compounds of Formula III, wherein the average number of —(CH2)4—SO3Na for the plurality of different compounds is from 6.0 to 7.1.